Anti-hyperglycemic and hypolipidemic effects of black ginseng extract containing increased Rh4, Rg5, and Rk1 content in muscle and liver of type 2 diabetic db/db mice.

Food Science and Biotechnology
Yu-Jin JeongKwang-Won Lee

Abstract

Black ginseng (BG), which is produced by repeated steaming and drying of fresh ginseng, has various pharmacological and therapeutic properties. This study investigated the anti-hyperglycemic and hypolipidemic effects of BG ethanolic extract in type 2 diabetic db/db mice. The levels of fasting blood glucose, HbA1c, insulin levels and thiobarbituric acid reactive substances values were decreased in the groups fed BG extract (BG) (100 and 900 mg/kg BW/day), compared to the control group (CON). In the BG compared with the CON, hepatic steatosis in the liver and the size of adipocytes in muscle tissue were improved. The administration of BG regulated the glucose transporter type (GLUT) 4 and 2, and peroxisome proliferator-activated receptor (PPAR) α and γ in muscle and liver. Moreover, ginsenosides (Rh4, Rg5, and Rk1), which profiled by HPLC, regulated the markers for lipid metabolism and glucose metabolism; PPARs and GLUTs in muscle and C2C12 rather than liver cells and tissue. These findings suggested that ginsenosides (Rh4, Rg5, and Rk1) from BG extract can ameliorate type 2 diabetes through their anti-hyperglycemic and hypolipidemic effects.

References

Jan 1, 1983·The American Journal of Chinese Medicine·M YamamotoY Yamamura
Jul 1, 1997·Biochemical Pharmacology·C N Gillis
Sep 23, 1997·Diabetologia·G D Holman, M Kasuga
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 20, 2003·Current Diabetes Reports·Jeanne M Clark, Anna Mae Diehl
Sep 12, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Seung Hwan Kim, Kyung Shin Park
Jan 19, 2005·Journal of Pharmacological Sciences·Ji Hyun KimInsop Shim
Mar 3, 2006·The Journal of Clinical Investigation·Philippe LefebvreBart Staels
Aug 12, 2006·Bioorganic & Medicinal Chemistry Letters·Ki Sung KangTakako Yokozawa
Oct 4, 2007·The Journal of Clinical Endocrinology and Metabolism·Christian HerderStephan Martin
Feb 8, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Joseph A Houmard
Jul 10, 2008·European Journal of Pharmacology·Ki Sung KangTakako Yokozawa
Apr 28, 2009·Journal of Pharmaceutical and Biomedical Analysis·Bai-Shen SunChang-Keun Sung
Jul 9, 2009·Physiological Reviews·Gregory R Steinberg, Bruce E Kemp
Jan 17, 2012·Journal of Cell Science·Jacqueline StöckliDavid E James
Aug 21, 2013·Biochemical and Biophysical Research Communications·Soon-Hee KimMyung-Sunny Kim
Nov 26, 2014·Diabetologia·Bernard Thorens
Dec 3, 2014·Diabetes & Metabolic Syndrome·C Janani, B D Ranjitha Kumari
May 10, 2016·Journal of Ginseng Research·Evelyn SabaMan-Hee Rhee
Dec 14, 2017·Pharmacological Reviews·Darren M RiddyChristopher J Langmead
Dec 12, 2018·Methods in Molecular Biology·Paul C Guest, Hassan Rahmoune
May 17, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ahmed M MetwalyDou Deqiang

❮ Previous
Next ❯

Citations

Dec 2, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Seong-Min Kim, Jee-Young Imm
May 25, 2021·Journal of Ginseng Research·Sang Jun YoonKi Tae Suk
Jul 20, 2021·Critical Reviews in Food Science and Nutrition·Priyanka ChopraRavi Gupta
Oct 27, 2021·Critical Reviews in Food Science and Nutrition·Min ZhouXi Ma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.